Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hcw Biologics Inc. (HCWB) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hcw Biologics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1828673.
Total stock buying since 2021: $10,631,302.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $19,701.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 133,398 | $3,045,054 | 0 | $0 | 0 | $0 |
| 2023 | 234,644 | $420,798 | 0 | $0 | 89,106 | $12,473 |
| 2022 | 138,472 | $342,049 | 0 | $0 | 16,285 | $2,849 |
| 2021 | 887,570 | $6,823,401 | 0 | $0 | 31,285 | $4,379 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 133,398 | $3,045,054 | 0 | $0 | 0 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 21,501 | $3,010 |
| 2023-11 | 0 | $0 | 0 | $0 | 15,000 | $2,100 |
| 2023-10 | 0 | $0 | 0 | $0 | 47,249 | $6,614 |
| 2023-09 | 34,450 | $69,848 | 0 | $0 | 0 | $0 |
| 2023-06 | 95,358 | $184,527 | 0 | $0 | 5,356 | $749 |
| 2023-05 | 104,836 | $166,423 | 0 | $0 | 0 | $0 |
| 2022-09 | 40,000 | $105,300 | 0 | $0 | 0 | $0 |
| 2022-08 | 17,200 | $43,908 | 0 | $0 | 0 | $0 |
| 2022-06 | 81,272 | $192,841 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 14,570 | $2,549 |
| 2022-01 | 0 | $0 | 0 | $0 | 1,715 | $300 |
| 2021-12 | 10,000 | $24,150 | 0 | $0 | 4,285 | $599 |
| 2021-11 | 0 | $0 | 0 | $0 | 27,000 | $3,780 |
| 2021-08 | 56,320 | $229,251 | 0 | $0 | 0 | $0 |
| 2021-07 | 821,250 | $6,570,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | Wong Hing C (Chief Executive Officer) | Buy | 8,054 | 7.45 | 60,002 |
| 2025-05-16 | Winer Gary M | Buy | 1,342 | 7.45 | 9,997 |
| 2025-05-16 | Garrett Scott T | Buy | 13,423 | 7.45 | 100,001 |
| 2025-05-08 | Greene Rick S. | Buy | 962 | 26.00 | 25,012 |
| 2025-05-08 | Wong Hing C (Chief Executive Officer) | Buy | 92,500 | 26.00 | 2,405,000 |
| 2025-05-08 | Byam Rebecca (Chief Financial Officer) | Buy | 8,462 | 26.00 | 220,012 |
| 2025-05-08 | Flowers Lee (SVP of Business Development) | Buy | 962 | 26.00 | 25,012 |
| 2025-05-08 | Winer Gary M | Buy | 2,308 | 26.00 | 60,008 |
| 2025-05-08 | Garrett Scott T | Buy | 5,385 | 26.00 | 140,010 |
| 2023-12-11 | Rhode Peter (See Remarks) | Option Ex | 14,000 | .14 | 1,960 |
| 2023-12-08 | Flowers Lee (SVP of Business Development) | Option Ex | 7,501 | .14 | 1,050 |
| 2023-11-17 | Rhode Peter (See Remarks) | Option Ex | 15,000 | .14 | 2,100 |
| 2023-10-19 | Byam Rebecca (Chief Financial Officer) | Option Ex | 47,249 | .14 | 6,614 |
| 2023-09-14 | Wong Hing C (Chief Executive Officer) | Buy | 1,800 | 2.08 | 3,740 |
| 2023-09-14 | Winer Gary M (Director) | Buy | 1,041 | 2.06 | 2,149 |
| 2023-09-13 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 2.10 | 10,490 |
| 2023-09-13 | Winer Gary M (Director) | Buy | 546 | 2.02 | 1,105 |
| 2023-09-12 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 2.09 | 10,440 |
| 2023-09-12 | Winer Gary M (Director) | Buy | 500 | 2.05 | 1,025 |
| 2023-09-11 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 2.06 | 10,275 |
| 2023-09-11 | Winer Gary M (Director) | Buy | 99 | 2.05 | 202 |
| 2023-09-08 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 2.02 | 10,109 |
| 2023-09-08 | Winer Gary M (Director) | Buy | 1 | 1.90 | 1 |
| 2023-09-07 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 1.95 | 9,740 |
| 2023-09-07 | Winer Gary M (Director) | Buy | 63 | 1.95 | 122 |
| 2023-09-06 | Byam Rebecca (Chief Financial Officer) | Buy | 5,000 | 1.95 | 9,750 |
| 2023-09-05 | Winer Gary M (Director) | Buy | 400 | 1.75 | 700 |
| 2023-06-09 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 2.06 | 41,280 |
| 2023-06-08 | Byam Rebecca (Chief Financial Officer) | Buy | 4,696 | 2.21 | 10,387 |
| 2023-06-08 | Flowers Lee (SVP of Business Development) | Buy | 10,000 | 2.16 | 21,570 |
| 2023-06-08 | Flowers Lee (SVP of Business Development) | Option Ex | 5,356 | .14 | 749 |
| 2023-06-07 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 2.03 | 40,640 |
| 2023-06-06 | Byam Rebecca (Chief Financial Officer) | Buy | 19,062 | 1.82 | 34,788 |
| 2023-06-05 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 1.67 | 33,340 |
| 2023-06-02 | Wong Hing C (Chief Executive Officer) | Buy | 800 | 1.53 | 1,228 |
| 2023-06-01 | Wong Hing C (Chief Executive Officer) | Buy | 800 | 1.62 | 1,294 |
| 2023-05-31 | Wong Hing C (Chief Executive Officer) | Buy | 2,000 | 1.55 | 3,092 |
| 2023-05-31 | Winer Gary M (Director) | Buy | 500 | 1.50 | 750 |
| 2023-05-30 | Wong Hing C (Chief Executive Officer) | Buy | 3,000 | 1.55 | 4,659 |
| 2023-05-30 | Winer Gary M (Director) | Buy | 850 | 1.52 | 1,292 |
| 2023-05-26 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 1.66 | 33,200 |
| 2023-05-25 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 1.62 | 32,340 |
| 2023-05-24 | Byam Rebecca (Chief Financial Officer) | Buy | 20,000 | 1.61 | 32,160 |
| 2023-05-23 | Byam Rebecca (Chief Financial Officer) | Buy | 5,036 | 1.57 | 7,886 |
| 2023-05-22 | Byam Rebecca (Chief Financial Officer) | Buy | 33,450 | 1.53 | 51,044 |
| 2022-09-13 | Byam Rebecca (Chief Financial Officer) | Buy | 15,000 | 2.58 | 38,655 |
| 2022-09-12 | Byam Rebecca (Chief Financial Officer) | Buy | 15,000 | 2.65 | 39,765 |
| 2022-09-09 | Wong Hing C (Chief Executive Officer) | Buy | 6,000 | 2.70 | 16,200 |
| 2022-09-08 | Wong Hing C (Chief Executive Officer) | Buy | 4,000 | 2.67 | 10,680 |
| 2022-08-31 | Byam Rebecca (Chief Financial Officer) | Buy | 10,000 | 2.56 | 25,570 |
| 2022-08-30 | Byam Rebecca (Chief Financial Officer) | Buy | 7,200 | 2.55 | 18,338 |
| 2022-06-14 | Byam Rebecca (Chief Financial Officer) | Buy | 58,856 | 2.46 | 144,962 |
| 2022-06-13 | Byam Rebecca (Chief Financial Officer) | Buy | 7,596 | 2.08 | 15,814 |
| 2022-06-10 | Wong Hing C (Chief Executive Officer) | Buy | 1,520 | 2.19 | 3,325 |
| 2022-06-10 | Winer Gary M (Director) | Buy | 1,500 | 2.13 | 3,199 |
| 2022-06-09 | Wong Hing C (Chief Executive Officer) | Buy | 2,000 | 2.25 | 4,490 |
| 2022-06-09 | Winer Gary M (Director) | Buy | 1,000 | 2.20 | 2,200 |
| 2022-06-08 | Winer Gary M (Director) | Buy | 1,000 | 2.27 | 2,273 |
| 2022-06-07 | Wong Hing C (Chief Executive Officer) | Buy | 1,000 | 2.31 | 2,310 |
| 2022-06-07 | Winer Gary M (Director) | Buy | 1,000 | 2.10 | 2,100 |
| 2022-06-06 | Winer Gary M (Director) | Buy | 1,000 | 2.13 | 2,127 |
| 2022-06-02 | Greene Rick S. (Director) | Buy | 4,800 | 2.09 | 10,041 |
| 2022-05-31 | Jiao Jin-an (VP of Development) | Option Ex | 14,570 | .17 | 2,549 |
| 2022-01-14 | Rhode Peter (See Remarks) | Option Ex | 1,715 | .17 | 300 |
| 2021-12-06 | Jiao Jin-an (VP of Development) | Buy | 10,000 | 2.42 | 24,150 |
| 2021-12-01 | Flowers Lee (SVP of Business Development) | Option Ex | 4,285 | .14 | 599 |
| 2021-11-23 | Byam Rebecca (Chief Financial Officer) | Option Ex | 27,000 | .14 | 3,780 |
| 2021-08-31 | Wong Hing C (Chief Executive Officer) | Buy | 3,830 | 3.94 | 15,071 |
| 2021-08-30 | Wong Hing C (Chief Executive Officer) | Buy | 6,000 | 3.93 | 23,598 |
| 2021-08-27 | Wong Hing C (Chief Executive Officer) | Buy | 6,000 | 3.77 | 22,620 |
| 2021-08-26 | Wong Hing C (Chief Executive Officer) | Buy | 6,500 | 3.84 | 24,973 |
| 2021-08-23 | Flowers Lee (SVP of Business Development) | Buy | 5,605 | 3.95 | 22,156 |
| 2021-08-20 | Flowers Lee (SVP of Business Development) | Buy | 7,853 | 4.08 | 32,071 |
| 2021-08-19 | Byam Rebecca (Chief Financial Officer) | Buy | 10,000 | 4.40 | 43,980 |
| 2021-08-19 | Flowers Lee (SVP of Business Development) | Buy | 10,532 | 4.25 | 44,782 |
| 2021-07-22 | Rhode Peter (See Remarks) | Buy | 12,500 | 8.00 | 100,000 |
| 2021-07-22 | Wong Hing C (Chief Executive Officer) | Buy | 627,500 | 8.00 | 5,020,000 |
| 2021-07-22 | Byam Rebecca (Chief Financial Officer) | Buy | 25,000 | 8.00 | 200,000 |
| 2021-07-22 | Flowers Lee (SVP of Business Development) | Buy | 31,250 | 8.00 | 250,000 |
| 2021-07-22 | Garrett Scott T (Director) | Buy | 125,000 | 8.00 | 1,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of HCWB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hcw Biologics Inc. (symbol HCWB, CIK number 1828673) see the Securities and Exchange Commission (SEC) website.